DiPEP(妊娠期肺栓塞诊断)生物标志物研究:一项观察性队列研究并附加病例以确定妊娠期和产褥期疑似静脉血栓栓塞生物标志物的诊断效用
该观察性队列研究纳入310例疑似肺栓塞的妊娠/产后女性和18例确诊深静脉血栓女性,评估多种生物标志物对静脉血栓栓塞的诊断效用。主要分析限于影像学结论明确的女性(36例静脉血栓栓塞,247例无)。各生物标志物AUC在0.524至0.702之间,未发现可用于诊断或排除静脉血栓栓塞的有用阈值。
要点
- 在妊娠和产褥期,常规及候选生物标志物对静脉血栓栓塞的诊断无阴性或阳性预测价值。
- 凝血酶生成滞后时间AUC最高为0.702,但未发现诊断有用阈值。
- 研究纳入310例疑似肺栓塞和18例确诊深静脉血栓的妊娠/产后女性。
核心结论
- 在妊娠和产褥期,常规和候选生物标志物在静脉血栓栓塞诊断中无论阴性或阳性预测值均无效用。
研究设计与样本
- 观察性队列研究,研究护士/助产士从310例疑似肺栓塞的妊娠/产后女性和18例确诊深静脉血栓女性中采集血样。
主要发现
- 主要分析限于影像学结论明确的女性,其中36例静脉血栓栓塞,247例无静脉血栓栓塞。
- 活化部分凝血活酶时间AUC为0.669(95%CI 0.570-0.768)。
- B型利钠肽AUC为0.549(95%CI 0.453-0.645)。
- C反应蛋白AUC为0.542(95%CI 0.445-0.639)。
- Clauss纤维蛋白原AUC为0.589(95%CI 0.476-0.701)。
关键数值与推荐
- D-二聚体(酶联免疫吸附法)AUC为0.668(95%CI 0.561-0.776)。
- 即时检测D-二聚体AUC为0.651(95%CI 0.545-0.758)。
- 中段心房利钠肽原AUC为0.524(95%CI 0.418-0.630)。
- 凝血酶原片段1+2 AUC为0.562(95%CI 0.462-0.661)。
- 纤溶酶-抗纤溶酶复合物AUC为0.639(95%CI 0.536-0.742)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study aimed to estimate the diagnostic utility of biomarkers for suspected venous thromboembolism (VTE) in pregnancy and the puerperium. Research nurses/midwives collected blood samples from 310 pregnant/postpartum women with suspected pulmonary emboli (PE) and 18 with diagnosed deep vein thrombosis (DVT). VTE was diagnosed using imaging, treatment and adverse outcome data. Primary analysis was limited to women with conclusive imaging (36 with VTE, 247 without). The area under the curve (AUC) for each biomarker was: activated partial thromboplastin time 0·669 (95% confidence interval 0·570-0·768), B-type natriuretic peptide 0·549 (0·453-0·645), C-reactive protein 0·542 (0·445-0·639), Clauss fibrinogen 0·589 (0·476-0·701), D-Dimer (by enzyme-linked immunosorbent assay) 0·668 (0·561-0·776), near-patient D-Dimer 0·651 (0·545-0·758), mid-regional pro-atrial natriuretic peptide 0·524 (0·418-0·630), prothrombin fragment 1 + 2 0·562 (0·462-0·661), plasmin-antiplasmin complexes 0·639 (0·536-0·742), prothombin time 0·613 (0·508-0·718), thrombin generation lag time 0·702 (0·598-0·806), thrombin generation endogenous potential 0·559 (0·437-0·681), thrombin generation peak 0·596 (0·478-0·715), thrombin generation time to peak 0·655 (0·541-0·769), soluble tissue factor 0·531 (0·424-0·638) and serum troponin 0·597 (0·499-0·695). No diagnostically useful threshold for diagnosing or ruling out VTE was identified. In pregnancy and the puerperium, conventional and candidate biomarkers have no utility either for their negative or positive predictive value in the diagnosis of VTE.
引用
- Hunt BJ, Parmar K, Horspool K, et al. The DiPEP (Diagnosis of PE in Pregnancy) biomarker study: An observational cohort study augmented with additional cases to determine the diagnostic utility of biomarkers for suspected venous thromboembolism during pregnancy and puerperium. Br J Haematol. 2018. PMID: 29359796. doi:10.1111/bjh.15102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。